Label Changes for:
Prevacid (lansoprazole) Delayed-Release Capsules and Prevacid Solutab (lansoprazole) Delayed-Release Orally Disintegrating Tablets
October 2011
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011
DRUG INTERACTIONS
Clopidogrel
- Concomitant administration of lansoprazole and clopidogrel in healthy subjects had no clinically important effect....
also see:
CLINICAL PHARMACOLOGY
Pharmacokinetics
- Clopidogrel...
